Biocryst Pharmaceuticals (BCRX) Current Taxes (2015 - 2021)

Biocryst Pharmaceuticals' Current Taxes history runs 7 years deep, the most recent figure standing at $2.6 million for Q4 2021.

• Quarterly Current Taxes rose 3177.5% year-over-year to $2.6 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2.6 million (up 3177.5% YoY) and the FY2021 annual result came in at $2.6 million, up 3177.5% from the prior year.
• Current Taxes was $2.6 million for Q4 2021 at Biocryst Pharmaceuticals, up from $80000.0 in the prior quarter.
• Across five years, Current Taxes topped out at $2.6 million in Q4 2021 and bottomed at $51000.0 in Q4 2018.
• A 5-year average of $593600.0 and a median of $80000.0 in 2020 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2018 — Current Taxes tumbled 65.54% — and 2021, when it surged 3177.5%.
• Biocryst Pharmaceuticals' Current Taxes stood at $148000.0 in 2017, then sank by 65.54% to $51000.0 in 2018, then surged by 31.37% to $67000.0 in 2019, then advanced by 19.4% to $80000.0 in 2020, then jumped by 3177.5% to $2.6 million in 2021.
• Business Quant data shows BCRX's Current Taxes at $2.6 million in Q4 2021, $80000.0 in Q4 2020, and $67000.0 in Q4 2019.